Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. Image by Getty.

News | Structural Heart

Smidt Heart Institute Physicians Advance Transcatheter Tricuspid Valve Replacement

February 9, 2024 — Physicians in the Smidt Heart Institute at Cedars-Sinai have achieved two significant firsts ...

February 09, 2024

ResearcherLate-breaking science from the American Stroke Association’s International Stroke Conference, ISC 2024, reports researchers found an artificial intelligence (AI) system to help guide treatment decisions for stroke patients led to improved stroke care quality and fewer recurrent strokes, heart attacks and vascular death among stroke survivors three months after a stroke.

News | AHA

International Stroke Conference Researcher Finds AI-based System Helped Guide Treatment, Lowered Stroke Recurrence

February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association’s Internation ...

February 08, 2024

Late-breaking science from a multi-center U.S. trial presented during the International Stroke Conference found that a flat head position for stroke patients before surgical removal of a blood clot in the brain (thrombectomy) may lead to better outcomes.

News | AHA

ISC 2024 Late-breaking Science Finding from ZODIAC Study: Position of Head Before Surgery May Improve Stroke Patient’s Neurological Function

February 7, 2024 — According to results from a multi-center trial in the United States, called Zero Degree Head ...

February 07, 2024

STROKE AF study shows long-term continuous cardiac monitoring delivers strong economic value driven by fewer projected lifetime strokes

News | Stroke

Medtronic LINQ Insertable Cardiac Monitors Prove Cost-effective Compared to Standard of Care in Ischemic Stroke Patients with Suspected Atrial Fibrillation

February 7, 2024 — Medtronic announced new cost-effectiveness data from the STROKE AF clinical study, which showed that ...

February 07, 2024

The brain has about 100 billion cells called neurons. It’s made up of distinct parts, that developed though human evolution. Copyright American Heart Association

News | Stroke

Nerve Stimulation Plus Intense Rehab May Improve Arm and Hand Function After Stroke

February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover ...

February 07, 2024

Findings from the highly-anticipated MOST (Multi-Arm Optimization of Stroke Thrombolysis) trial were presented on the first day of the American Stroke Association’s International Stroke Conference, ISC 2024, being held through Feb. 9 in Phoenix, AZ.

News | AHA

Findings from MOST Trial Presented at ISC24: Blood thinners added to clot-busting medication did not improve stroke outcomes

February 7, 2024 — Researchers presenting preliminary late-breaking science presented on the first day of the American ...

February 07, 2024

New phenomapping tool and clinical score could lead to personalized strategies for patients hospitalized with ADHF

News | Artificial Intelligence

Machine Learning Informs a New Tool to Guide Treatment for Acute Decompensated Heart Failure

February 6, 2024 — A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The ...

February 06, 2024

ATTRibute-CM results also demonstrated rapid clinical benefit on the composite endpoint of all-cause mortality (ACM) and CVH in patients treated with acoramidis, with time-to-first event Kaplan-Meier curves separating at month 3 and continuing to diverge steadily through Month 30

News | FDA

BridgeBio Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application (NDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

February 6, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

February 06, 2024

EGF Mapping system aims to improve patient outcomes by enabling precise and personalized ablation strategies

News | Atrial Fibrillation

Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow (EGF) Mapping for use in Atrial Fibrillation Ablation

February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...

February 06, 2024

News | Atrial Fibrillation

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

February 2, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

February 02, 2024

In addressing efficacy, harm, and logistics, the study passes all three of the criteria suggested by the American Heart Association guiding the implementation of polygenic risk scores (PRSs) in cardiovascular care

News | Cardiovascular Clinical Studies

Genomics plc Publishes Clinical Trial Results Demonstrating Successful Integration and Clinical Utility of Integrated Risk Scores Combining Polygenic and Clinical Risk of Cardiovascular Disease in NHS Primary Care

February 1, 2024 — Genomics plc (Genomics), a healthcare company aiming to transform health through the power of ...

February 01, 2024

The U.S. Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System.

News | FDA

Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System

January 31, 2024 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) appro ...

January 31, 2024

The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio

News | STS

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

January 29, 2024 — The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at ...

January 29, 2024

While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to this guest column author who addresses the importance of identifying and reducing residual inflammatory risk.

Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

January 23, 2024

Data from non-randomized cohort confirms dramatic improvement in diuretic response and at least 95% reduction in loop diuretic requirements up to almost four months after last DSR therapy

News | Heart Failure

Sequana Medical Announces DSMB Approval to Start Randomized MOJAVE Cohort

January 23, 2024 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

January 23, 2024